APOE and Alzheimer disease: Specifically, AD patients with APOE ε4/ε4 and high TyG index showed significantly higher CSF/serum albumin levels (F = 4.753, p = 0.001) and CSF/serum λ FLCs levels (F = 3.689; p = 0.005) as compared to the other AD subgroups.